Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)
- Rodrigues, J.S.
- Chenlo, M.
- Bravo, S.B.
- Perez-Romero, S.
- Suarez-Fariña, M.
- Sobrino, T.
- Sanz-Pamplona, R.
- González-Prieto, R.
- Blanco Freire, M.N.
- Nogueiras, R.
- López, M.
- Fugazzola, L.
- Cameselle-Teijeiro, J.M.
- Alvarez, C.V.
Revista:
Nature Communications
ISSN: 2041-1723
Ano de publicación: 2024
Volume: 15
Número: 1
Tipo: Errata
